Smith & Wesson Brands (SWBI) Investor Day 2026 presentation summary
Event summary combining transcript, slides, and related documents.
Investor Day 2026 presentation summary
19 Jul, 2026Strategic transformation and growth
Transitioned to a pure-play firearms company, focusing on core mission and operational modernization since 2020.
Expanded capabilities with digital transformation, analytics, and business intelligence investments.
Entered new categories such as suppressors and hunting, and launched new platforms like lever-action rifles.
Introduced over 250 new SKUs in FY26, with 38.1% of revenue from new products.
Achieved 12.7% YoY increase in firearms shipped and over 10% net revenue growth in FY26.
Market position and financial performance
Gained market share, reaching 16% US commercial unit share and 17% share in handgun units.
Maintained leadership in modern sporting rifles and handguns, with ongoing revolver innovation.
Generated $114.2M in cash from operations, reduced debt by $60M, and paid $23.2M in dividends in FY26.
Over 20 industry awards for new products launched in the last three years.
Growth opportunities and market outlook
Addressable global small arms market estimated at $8B–$10B in 2025, with 4–6% CAGR through 2032.
US commercial market represents 43% of the total, with significant opportunities in law enforcement and international markets.
Suppressors identified as a high-growth adjacent category, with 95.6% revenue growth in first half of 2026 after tax stamp removal.
Latest events from Smith & Wesson Brands
- Strong Q4 and FY26 results, with robust growth, margin gains, and positive outlook for FY27.SWBI
Q4 202617 Jun 2026 - Q3 net sales up 17.1% to $135.7M, with higher margins and strong Q4 outlook.SWBI
Q3 20265 Mar 2026 - Double-digit growth in revenue and net income, with 2025 outlook for continued gains and higher dividends.SWBI
Q4 20243 Feb 2026 - Q1 sales fell 22.7%, but new products and margin gains support a positive full-year outlook.SWBI
Q1 202522 Jan 2026 - Board re-elections, executive pay approval, and strong financial growth highlighted the meeting.SWBI
AGM 202420 Jan 2026 - Q2 sales up 3.8% to $129.7M, but guidance cut as inflation softens demand and margins.SWBI
Q2 202511 Jan 2026 - Q3 sales fell 15.7% as new products drove 41% of revenue, but margins and sales remain pressured.SWBI
Q3 202527 Dec 2025 - Q2 sales dipped 3.9% but cash flow and new product momentum support a strong Q3 outlook.SWBI
Q2 20267 Dec 2025 - Director elections, say-on-pay, and a human rights proposal headline a governance-focused agenda.SWBI
Proxy Filing1 Dec 2025